Regarding the association of AR/FOXA1 status with HER2 in the present study, TMA analysis and public dataset showed no statistical significance in ER-positive cancers, although decreased HER2 protein was noted by experiments overexpressing AR or FOXA1 (Figure 2C). The gene discussed is ERBB2; the disease is cancer.